Citations

Clear

33 citation(s) found for "Team, A4 Study".

Faculty Opinions recommendation of Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
Ryu, Jay H.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 2, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726361294.793524894 Get It

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis
Choung, Rok Seon , Princen, Fred, Stockfisch, Thomas P. , Torres, Joana , Maue, Alexander C., Porter, Chad K., Vroey, Bénédicte De, Singh, Sharat , Riddle, Mark S. , Team, the PREDICTS Study, Porter, Chad K. , Leon, F., Murray, Joseph A. , Colombel, Jean‐Frédéric , Team, the PREDICTS Study, Torres, Joana , Choung, Rok Seon

Mayo Clinic

Alimentary Pharmacology & Therapeutics | April 27, 2016 | Volume: 43 | Issue: 12 | Pages: 1300-1310

10.1111/apt.13641 | PMID 27117843 Get It

Summary Background Patients with Crohn's disease ( CD ) have serologic responses to various microbial antigens. Serologic markers are associated with aggressive forms of disease and can be detected before onset of symptoms. Their utility in pre‐clinical disease or prediction of complicated disease course before diagnosis is unclear. Aim To evaluate the pattern of serologic anti‐microbial antibodies long prior to diagnosis and the subsequent risk of complicated Crohn's disease at diagnosis. Methods Sera from 100 US military personnel with Crohn's disease were obtained from the Department of Defense Serum Repository. For each patient, four samples were obtained at different time points before and around diagnosis, and were tested for 6 microbiota‐directed antibodies ( ASCA ‐IgA, ASCA ‐IgG, anti‐OmpC, anti‐ CB ir1, anti‐A4‐Fla2 and anti‐FlaX). Associations between the presence and accumulation of Crohn's disease anti‐microbial antibodies before diagnosis and with the later development of complications were evaluated. Results Overall, 65 patients were positive for at least one Crohn's disease associated anti‐microbial antibody in the earliest available sample, at a median of 6 years before Crohn's disease diagnosis (interquartile range, 5.6–8.2). The number of positive anti‐microbial antibodies increased up to the time of Crohn's disease diagnosis. Complicated disease developed around the time of diagnosis in 24 patients. The proportion of positive antimicrobial antibodies before diagnosis was higher in patients with complicated vs. noncomplicated Crohn's disease. There was an inverse relationship between the time to first complication and the magnitude of serologic response before diagnosis. Conclusion The presence and accumulation of circulating anti‐microbial antibodies years before Crohn's disease diagnosis was associated with complicated Crohn's disease at or shortly after diagnosis.
HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation
Baker, Jason V. , Brummel‐Ziedins, Kathleen E., Neuhaus, Jacqueline, Dalmau, David , Lehmann, Clara , Sullivan, Ann , Woolley, Ian , Kuller, Lewis H. , Neaton, James D. , Team, INSIGHT SMART Study, Duprez, Daniel A. , Cummins, Nathan W. , DeHovitz, Jack A. , Tracy, Russell P. , Team, INSIGHT SMART Study, Nordwall, Jacqueline

Mayo Clinic

Journal of the American Heart Association | July 29, 2013 | Volume: 2 | Issue: 4 | Pages: No page available

10.1161/jaha.113.000264 | PMID 23896681 Get It

Background HIV infection leads to activation of coagulation, which may increase the risk for atherosclerosis and venous thromboembolic disease. We hypothesized that HIV replication increases coagulation potentially through alterations in extrinsic pathway factors. Methods and Results Extrinsic pathway factors were measured among a subset of HIV participants from the Strategies for Management of Anti‐Retroviral Therapy ( SMART ) trial. Thrombin generation was estimated using validated computational modeling based on factor composition. We characterized the effect of antiretroviral therapy ( ART ) treatment versus the untreated state ( HIV replication) via 3 separate analyses: (1) a cross‐sectional comparison of those on and off ART (n=717); (2) a randomized comparison of deferring versus starting ART (n=217); and (3) a randomized comparison of stopping versus continuing ART (n=500). Compared with viral suppression, HIV replication consistently showed short‐term increases in some procoagulants (eg, 15% to 23% higher FVIII ; P <0.001) and decreases in key anticoagulants (eg, 5% to 9% lower antithrombin [ AT ] and 6% to 10% lower protein C; P <0.01). The net effect of HIV replication was to increase coagulation potential (eg, 24% to 48% greater thrombin generation from computational models; P <0.01 for all). The pattern of changes from HIV replication was reversed with ART treatment and consistent across all 3 independent comparisons. Conclusions HIV replication leads to complex changes in extrinsic pathway factors, with the net effect of increasing coagulation potential to a degree that may be clinically relevant. The key influence of changes in FVIII and AT suggests that HIV ‐related coagulation abnormalities may involve changes in hepatocyte function in the context of systemic inflammation. Clinical Trial Registration URL: ClinicalTrials.gov . Unique identifier: NCT 00027352.